FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Plan Would Fundamentally Reshape Drug Ads

[ Price : $8.95]

Two Sheppard attorneys say an FDA proposal to require complete safety and risk information within the content of direct-to-consume...

FDA, Industry Have MDUFA 6 Agreement in Principle

[ Price : $8.95]

Attorney Jake Leys says MDUFA 6 reauthorization has moved from negotiations into writing the commitment letter that spells out all...

FDA Approves GSK's Jideytro for ROS1-Positive Lung Cancer

[ Price : $8.95]

FDA approves GSK's Jideytro (zidesamtinib) for certain adults with locally advanced or metastatic ROS1-positive non-small cell lun...

FDA Reform Requires a Whole-of-System Strategy: Editorial

[ Price : $8.95]

A Cureus Journal of Medical Science open-source editorial calls for a rebuilding of the U.S. scientific infrastructure as the only...

House Passes FDA Modernization Act 3.0 for Reducing Animal Testing

[ Price : $8.95]

The U.S. House of Representatives passes the FDA Modernization Act 3.0 (H.R. 2821), advancing bipartisan legislation intended to a...

FDA Cites Sanofi Over Misleading Beyfortus Promotional Emails

[ Price : $8.95]

FDA sends an untitled letter to Sanofi Vaccines U.S., alleging that promotional emails for its respiratory syncytial virus prevent...

Novo Nordisk Sues Lilly Over GLP-1 Ads

[ Price : $8.95]

Novo Nordisk sues Lilly in New Jersey federal court over what the company says is a misleading national ad campaign that compares ...

CGMP Issues at Indias Shimoga Chemicals

[ Price : $8.95]

FDA warns Indias Shimoga Chemicals about CGMP deviations in its production of active pharmaceutical ingredients.

No Informed Consent in Alembic Trial

[ Price : $8.95]

FDA warns Indias Alembic Research Center that it failed to obtain informed consent for an in vivo bioequivalence study.

Acadia Gets Fast Track for Alzheimers Psychosis Drug

[ Price : $8.95]

FDA awards Acadia Pharmaceuticals a Fast Track designation for remlifanserin, an investigational, highly selective, 5-HT2A recepto...